This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Oesophagus
CD2_BENIGN_OESOPHAGUS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum oesophagi
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Oesophagus
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Oesophagus
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 416 | 222 | 194 |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | 0.09 |
| Median age at first event (years) | 61.02 | 58.92 | 63.42 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 383
- Matched controls
- 3828
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
4503599627370496.0
323.0
371
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
17.5
131.2
307
716
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
44.7
42
*
130
Kela drug reimbursment
Malignant tumour
+∞
42.5
40
*
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
+∞
38.2
36
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
17.3
33.8
54
36
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
5.4
29.1
97
226
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
28.8
29.0
39
15
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
39.5
28.9
36
10
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
22.2
27.6
40
20
JN4BD
NOMESCO Finland
Extensive body CT
8.8
25.4
56
73
A04AA02
ATC
granisetron; systemic, transdermal
+∞
25.3
24
*
JCA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in oesophagus
+∞
24.2
23
*
H02AB02
ATC
dexamethasone; systemic
30.5
23.6
31
11
UJD02
NOMESCO Finland
Gastroscopy
8.0
23.1
54
77
R13
ICD-10 Finland
Dysphagia
6.5
23.0
63
113
A02BC02
ATC
pantoprazole; systemic
3.1
21.8
285
1867
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
+∞
21.0
20
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
21.0
20
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
5.0
20.1
68
157
UJF32
NOMESCO Finland
Coloscopy
3.0
19.6
140
609
A02BC05
ATC
esomeprazole; systemic
2.7
19.3
197
1070
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
18.9
18
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
4.8
18.4
65
157
WF002
NOMESCO Finland
Radical radiotherapy
99.7
17.7
19
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
16.8
16
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
177.4
16.6
17
*
K22.7
ICD-10 Finland
Barrett oesophagus
16.3
16.4
26
17
UJC12
NOMESCO Finland
Flexible oesophagoscopy
31.6
16.3
21
7
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.1
16.0
30
29
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
+∞
15.7
15
*
K22.2
ICD-10 Finland
Oesophageal obstruction
30.0
15.3
20
7
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
15.2
104
428
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
15.0
188
1091
WX402
NOMESCO Finland
General anaesthesia
3.5
15.0
77
259
K22.1
ICD-10 Finland
Ulcer of oesophagus
10.7
14.2
27
27
JN4AD
NOMESCO Finland
Body CT examination
7.2
14.1
34
51
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
13.6
13
*
A02BC01
ATC
omeprazole; systemic
2.5
13.4
137
707
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
13.2
116
550
A03FA01
ATC
metoclopramide; systemic, rectal
3.3
12.9
70
243
A04AA01
ATC
ondansetron; systemic, rectal
9.8
12.7
25
27
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
12.1
89
380
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
11.5
11
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.5
11
*
WX002
NOMESCO Finland
Sedation and analgesia
2.6
11.5
97
444
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
36.2
11.3
14
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
44.7
11.0
13
*
ZXC96
NOMESCO Finland
Robot assisted procedure
61.8
10.7
12
*
A02BC03
ATC
lansoprazole; oral
2.2
10.7
135
757
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
113.0
10.5
11
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
10.5
10
*
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
+∞
10.5
10
*
C16.00
ICD-10 Finland
Cardia
+∞
10.5
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
10.5
10
*
JCA05
NOMESCO Finland
Endoscopic polypectomy in oesophagus
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
33.5
10.4
13
*
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
19.4
10.3
15
8
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.5
10.1
87
402
R4190
NOMESCO Finland
Nutritional therapy
6.8
9.9
24
37
N02AA05
ATC
oxycodone; systemic
2.8
9.6
63
249
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
+∞
9.4
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
N02BE01
ATC
paracetamol; systemic, rectal
2.4
9.3
327
2726
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
19.2
9.0
13
7
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
9.0
110
598
K20
ICD-10 Finland
Oesophagitis
8.3
9.0
19
24
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
24.7
9.0
12
5
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
8.7
77
358
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
8.7
43
140
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.3
8.6
17
19
L03AA02
ATC
filgrastim; parenteral
92.0
8.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
C15.3
ICD-10 Finland
Malignant neoplasm: Upper third of oesophagus
+∞
8.4
8
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
8.4
8
*
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.8
8.4
27
60
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
4.0
8.3
32
85
UJC02
NOMESCO Finland
Rigid oesophagoscopy
14.9
8.3
13
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
8.2
141
878
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
8.0
31
83
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.4
7.8
27
65
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
45.9
7.7
9
*
B01AB05
ATC
enoxaparin; parenteral
2.0
7.7
112
649
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
7.5
69
326
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
7.5
60
266
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
7.4
44
163
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.8
7.4
30
84
R4110
NOMESCO Finland
Physiotherapy
2.0
7.4
103
589
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
7.3
41
144
8140/3-C15.9
ICD-O-3
Adenocarcinoma, NOS, of esophagus, NOS
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
JCA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in oesophagus
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
JCA98
NOMESCO Finland
Other local endoscopic operation on oesophagus
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.1
7.3
39
135
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
7.3
97
541
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
7.2
58
257
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
3.8
7.2
29
81
WX600
NOMESCO Finland
Single shot through catheter
12.3
7.1
12
10
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
12.3
7.1
12
10
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
7.1
48
191
B01AB10
ATC
tinzaparin; parenteral
3.9
6.9
27
73
K90.0
ICD-10 Finland
Coeliac disease
5.2
6.9
20
40
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
6.8
97
556
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
40.8
6.8
8
*
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
40.8
6.8
8
*
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
3.9
6.7
26
70
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.9
6.7
26
70
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.8
6.7
21
46
N03AX16
ATC
pregabalin; oral
2.0
6.7
98
569
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.8
6.5
20
43
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
71.0
6.4
7
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.3
6.4
18
35
K30
ICD-10 Finland
Functional dyspepsia
2.6
6.4
47
198
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
JCA42
NOMESCO Finland
Other endoscopic procedure for hemostasis
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
C15.0
ICD-10 Finland
Malignant neoplasm: Cervical part of oesophagus
+∞
6.3
6
*
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
27.2
6.3
8
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
27.2
6.3
8
*
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
27.2
6.3
8
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
6.2
37
139
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
7.9
6.2
13
17
S18
ICPC
Laceration/cut
1.8
6.2
151
1037
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.0
6.1
33
116
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
10.3
6.1
11
11
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
6.1
63
317
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
86
230
4.45
29.95
2.7
1.8
0.2
0.2
g/l
0.27
78
206
277
1572
3.28
29.18
7.8
3.7
11.1
11.4
umol/l
0.22
266
1465
249
1334
3.16
28.92
7.7
3.6
35.1
35.8
g/l
0.97
231
1225
72
175
4.77
28.20
2.8
1.5
7.4
4.6
ug/l
0.40
64
132
353
2455
3.89
24.01
10.2
5.1
79.5
74.4
u/l
2.26
330
2249
190
1014
2.61
20.05
3.0
2.1
54.4
58.7
u/l
0.97
171
933
235
1388
2.59
20.04
11.3
4.9
1.2
1.2
mmol/l
0.05
209
1238
249
1521
2.59
19.64
12.1
5.6
1.2
1.2
mmol/l
0.12
208
1312
267
1696
2.60
19.24
11.5
6.2
4.4
4.2
e9/l
0.54
232
1482
160
800
2.63
19.13
2.9
2.1
3.1
3.1
mg/l
0.12
144
666
97
391
2.93
17.42
10.6
5.2
1.1
1.0
mmol/l
1.16
90
350
219
1338
2.34
16.17
5.3
3.5
—
—
—
0
0
277
1911
2.35
14.86
9.8
4.0
6.7
6.8
mmol/l
0.23
257
1776
130
663
2.40
14.21
4.4
1.9
—
—
—
0
0
102
469
2.56
13.92
3.5
2.4
10.7
13.6
umol/l
4.27
96
426
66
255
2.89
12.58
12.6
6.8
9.3
10.2
mmol/l
0.44
59
243
84
384
2.49
11.44
3.8
2.5
18.5
24.4
%
4.15
71
327
65
262
2.76
11.41
2.6
2.0
34.0
34.4
u/l
0.03
48
213
167
1032
2.03
10.75
3.7
2.1
2.3
2.3
mmol/l
0.38
142
852
206
1383
1.97
10.37
4.2
2.7
115.2
125.0
ug/l
0.25
190
1259
78
363
2.41
10.15
16.6
6.3
11.4
11.6
kpa
0.17
72
347
78
363
2.41
10.15
16.7
6.4
5.1
5.1
kpa
0.24
72
346
73
332
2.45
9.98
3.2
2.2
6.8
7.9
umol/l
0.27
61
286
77
362
2.38
9.78
16.8
6.4
1.3
1.6
mmol/l
0.19
64
283
79
379
2.34
9.57
16.0
5.6
104.1
104.2
mmol/l
0.09
79
369
138
828
2.00
9.42
1.8
1.5
21.5
21.4
nmol/l
0.02
124
702
160
1013
1.94
9.32
4.8
2.6
28.2
31.6
u/l
1.27
152
963
50
199
2.72
8.95
2.0
1.5
—
—
—
0
0
204
1414
1.87
8.89
2.4
2.0
95.8
95.5
pmol/l
0.03
120
721
167
1100
1.87
8.43
3.8
2.9
—
—
—
0
0
278
2159
1.87
8.09
4.1
2.8
55.7
45.7
u/l
1.07
247
1994
136
848
1.90
8.08
3.8
2.7
0.4
0.5
e6/l
0.52
101
635
356
3016
2.25
7.97
29.6
13.3
38.8
40.1
%
1.79
229
2064
306
2474
1.90
7.56
5.1
4.1
14.9
11.4
mm/h
2.71
272
2254
379
3319
2.60
7.49
26.0
12.0
22.5
23.2
mg/l
0.16
314
2516
112
671
1.92
7.43
4.5
3.9
645.6
302.4
ng/l
0.28
88
537
35
128
2.89
7.32
1.9
1.8
1.3
1.6
g/l
1.16
29
111
61
296
2.24
7.12
3.0
3.3
197.5
213.6
ng/l
0.13
55
274
33
120
2.90
6.98
1.2
1.3
3.5
3.9
g/l
0.77
24
87
33
120
2.90
6.98
1.2
1.3
6.9
7.6
g/l
1.56
26
91
32
120
2.81
6.41
1.3
1.3
—
—
—
0
0
88
512
1.91
6.29
3.0
2.5
1.0
1.1
e6/l
0.09
44
290
100
611
1.84
6.13
3.3
2.1
2.5
2.4
mmol/l
0.82
84
517
21
63
3.46
6.08
1.4
1.4
—
—
—
0
0
21
63
3.46
6.08
1.4
1.4
—
—
—
0
0
182
1320
1.67
6.07
2.7
2.3
74.0
77.5
nmol/l
0.98
159
1151
82
472
1.92
6.04
3.1
2.7
3.1
2.2
e6/l
0.26
39
250
51
248
2.20
5.91
4.6
3.7
112.0
86.5
ng/l
0.86
43
218
30
114
2.76
5.87
1.2
1.3
3.1
3.1
g/l
0.05
25
89
209
1589
1.63
5.68
3.7
3.5
0.0
0.0
estimate
0.00
32
279
103
652
1.77
5.57
2.0
1.8
1159.3
1205.9
nmol/l
0.16
74
482
28
110
2.66
5.16
2.0
1.9
412.2
692.9
ug/l
0.25
28
103
207
1595
1.59
5.15
5.1
4.7
0.0
0.0
estimate
0.50
33
277
123
841
1.66
4.96
2.7
2.4
3647.7
7137.9
umol/l
0.44
105
723
208
1617
1.57
4.90
3.7
3.5
0.0
0.0
estimate
0.50
31
272
318
2737
1.69
4.85
31.2
14.5
14.2
13.6
%
4.67
313
2680
383
3501
2.18
4.61
31.0
14.5
139.4
139.8
mmol/l
1.91
375
3397
54
296
1.95
4.56
4.0
3.2
—
—
—
0
0
44
224
2.08
4.56
8.0
3.0
1.2
1.2
mmol/l
0.40
38
190
350
3115
1.78
4.45
5.7
4.6
1.9
2.3
mu/l
0.51
322
2818
383
3509
2.15
4.45
31.2
14.6
4.0
4.0
mmol/l
0.77
375
3400
82
517
1.73
4.43
2.2
1.8
—
—
—
0
0
105
711
1.64
4.33
1.8
1.7
1.0
1.0
mg/l
0.04
79
559
24
97
2.56
4.21
1.1
1.2
—
—
—
0
0
54
309
1.86
4.02
4.4
3.1
1.8
2.2
mmol/l
0.32
47
245
14
43
3.33
3.94
1.1
1.1
—
—
—
0
0
13
38
3.50
3.93
1.3
1.4
—
—
—
0
0
19
71
2.76
3.88
1.5
1.7
—
—
—
0
0
23
97
2.45
3.72
1.1
1.2
—
—
—
0
0
12
35
3.50
3.64
1.7
1.1
—
—
—
0
0
12
35
3.50
3.64
1.7
1.1
—
—
—
0
0
12
35
3.50
3.64
1.7
1.1
—
—
—
0
0
16
58
2.83
3.46
1.6
1.6
—
—
—
0
0
60
374
1.71
3.36
2.1
1.8
—
—
—
0
0
60
375
1.70
3.33
2.1
1.8
—
—
—
0
0
15
54
2.84
3.29
1.5
1.4
—
—
—
0
0
170
1346
1.44
3.27
4.1
3.6
35.0
63.7
ng/l
0.55
111
953
35
188
1.94
3.17
1.6
1.4
—
—
—
0
0
97
691
1.53
3.15
1.4
1.2
0.5
2.0
u/ml
1.72
20
198
292
2569
1.46
3.07
4.5
3.7
14.5
14.9
pmol/l
2.07
272
2312
137
1052
1.45
3.06
3.0
2.8
1477.1
1266.5
ng/l
0.34
110
877
43
253
1.78
2.95
2.9
2.1
59.4
64.1
ml/min/173m2
0.35
19
100
11
35
3.20
2.95
1.7
1.1
—
—
—
0
0
11
35
3.20
2.95
1.7
1.1
—
—
—
0
0
11
35
3.20
2.95
1.7
1.1
—
—
—
0
0
7
13
5.46
2.88
1.7
2.1
—
—
—
0
0
138
1074
1.43
2.84
2.7
2.0
182.9
236.5
u/l
0.34
133
1008
8
18
4.51
2.81
1.6
1.1
—
—
—
0
0
15
61
2.51
2.65
1.2
1.4
—
—
—
0
0
383
3608
1.78
2.61
15.5
8.6
25.4
25.6
u/l
0.10
368
3455
15
62
2.47
2.57
3.1
2.5
14.0
16.6
%
—
8
28
12
44
2.78
2.57
1.3
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
88
2.21
2.55
3.6
2.4
0.2
0.4
u/ml
—
8
47
156
1263
1.38
2.49
3.8
3.6
—
—
—
0
0
54
357
1.59
2.43
1.9
1.7
1.9
1.5
%
0.96
42
306
28
157
1.84
2.28
1.3
1.3
—
—
—
0
0
392
3739
1.84
2.25
38.3
17.8
130.9
136.5
g/l
9.41
383
3666
26
145
1.85
2.16
1.2
1.0
—
—
—
0
0
32
194
1.70
2.03
2.0
1.6
—
—
—
0
0
15
71
2.15
1.94
1.7
1.2
—
—
—
0
0
11
45
2.48
1.94
2.7
2.5
5.2
4.3
e9/l
0.77
11
45
11
46
2.43
1.86
2.8
2.9
64.6
56.5
%
2.17
11
46
95
742
1.36
1.84
1.8
1.7
479.5
29054491.4
pmol/l
0.74
76
592
16
80
2.04
1.82
1.3
1.2
—
—
—
0
0
9
35
2.61
1.81
1.2
1.1
—
—
—
0
0
21
117
1.84
1.78
1.4
1.6
—
124.0
—
0
5
19
103
1.89
1.74
2.8
3.1
—
—
—
0
0
19
104
1.87
1.70
1.7
1.7
—
—
—
0
0
356
3364
1.40
1.65
5.5
4.7
6.0
6.0
mmol/l
0.07
327
3043
77
595
1.36
1.60
1.3
1.3
31.1
34.2
iu/ml
0.08
31
183
10
44
2.30
1.54
1.1
1.5
—
—
—
0
0
31
202
1.58
1.53
4.5
3.6
3.3
2.0
mmol/l
0.79
24
148
5
15
3.36
1.52
1.0
1.3
—
—
—
0
0
5
15
3.36
1.52
1.4
1.4
—
—
—
0
0
9
37
2.46
1.48
3.8
3.4
—
—
—
0
0
13
66
2.00
1.45
1.2
1.4
—
—
—
0
0
5
16
3.15
1.44
1.0
2.5
591.0
737.4
u/ml
—
5
16
14
74
1.92
1.40
1.9
1.4
—
—
—
0
0
63
482
1.36
1.40
1.5
1.5
—
—
—
0
0
13
67
1.97
1.39
1.5
1.2
—
—
—
0
0
16
89
1.83
1.39
1.4
1.4
—
—
—
0
0
15
83
1.84
1.33
1.4
1.6
—
—
—
0
0
14
76
1.87
1.31
1.6
1.7
3.2
5.8
iu/l
—
5
25
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
5
18
2.80
1.29
1.0
1.0
—
—
—
0
0
9
44
2.07
1.27
1.3
1.3
—
—
—
0
0
110
923
1.26
1.26
1.8
1.6
1.3
1.4
mmol/l
0.49
95
773
215
1940
1.22
1.26
3.1
2.8
—
—
—
0
0
13
73
1.81
1.12
1.2
1.3
—
—
—
0
0
333
3170
1.25
1.05
22.9
11.0
78.4
78.3
ml/min/173m2
0.03
279
2551
9
49
1.85
0.99
1.1
1.1
—
—
—
0
0
19
282
0.66
0.99
1.9
1.8
—
—
—
0
0
13
77
1.71
0.96
1.1
1.1
—
—
—
0
0
9
51
1.78
0.95
1.2
1.3
—
—
—
0
0
42
323
1.33
0.94
2.0
2.4
4.9
7.2
ug/l
1.02
37
275
6
27
2.24
0.94
1.0
1.3
—
—
—
0
0
15
94
1.62
0.92
1.3
1.6
—
—
—
0
0
6
30
2.01
0.87
1.0
1.3
—
—
—
0
0
68
567
1.24
0.84
1.4
1.3
31.6
12.4
u/ml
0.66
29
209
130
1161
1.17
0.78
3.9
3.9
5.7
7.8
mg/mmol
0.56
82
721
87
753
1.20
0.75
3.9
3.7
1.0
1.0
kg/l
2.12
12
108
7
39
1.81
0.73
1.1
1.4
—
—
—
0
0
7
40
1.76
0.71
1.3
1.4
—
—
—
0
0
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
5
26
1.93
0.71
1.2
1.1
—
—
—
0
0
334
3220
1.19
0.70
6.5
6.1
40.0
40.3
mmol/mol
0.19
299
2974
7
42
1.68
0.68
1.4
1.4
152.0
359.1
pmol/l
—
7
34
53
442
1.23
0.67
1.6
1.4
—
—
—
0
0
12
81
1.50
0.57
1.3
1.2
—
—
—
0
0
54
461
1.20
0.56
4.8
4.8
34.1
32.1
%
0.87
38
296
11
74
1.50
0.54
4.5
3.6
0.8
0.8
nmol/l
0.01
11
57
6
40
1.51
0.52
1.0
1.3
—
—
—
0
0
336
3268
1.15
0.49
4.1
4.1
1.3
1.3
mmol/l
0.17
301
2963
7
47
1.50
0.48
1.9
1.1
—
—
—
0
0
5
31
1.62
0.43
1.6
1.4
—
—
—
0
0
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
8
58
1.39
0.41
1.3
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
8
59
1.36
0.41
2.4
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
11
80
1.39
0.39
1.3
1.2
—
10.5
—
0
8
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
94
869
1.11
0.34
4.6
3.8
0.0
0.0
estimate
0.50
30
274
347
3406
1.11
0.32
4.6
4.7
4.5
4.6
mmol/l
0.88
317
3128
344
3380
1.10
0.29
4.6
4.6
1.4
1.5
mmol/l
2.50
310
3094
5
72
0.69
0.26
1.2
1.3
—
218.1
—
0
36
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
13
157
0.82
0.23
2.0
2.8
0.1
0.2
e6/l
0.17
13
151
0
10
0.00
0.21
0.0
1.6
—
15.0
—
0
5
8
103
0.77
0.21
2.4
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
26
231
1.13
0.20
2.0
1.9
—
—
—
0
0
352
3477
1.08
0.20
5.3
5.2
2.7
2.7
mmol/l
0.45
321
3186
11
90
1.23
0.19
1.5
1.4
—
—
—
0
0
7
58
1.21
0.18
1.6
1.4
65.8
58.7
pmol/l
—
7
58
14
119
1.18
0.18
1.3
2.2
—
—
—
0
0
13
111
1.18
0.16
2.5
1.4
—
—
—
0
0
12
102
1.18
0.15
1.3
1.2
—
3.4
—
0
19
9
80
1.13
0.15
1.4
1.2
—
39.4
—
0
7
14
121
1.16
0.15
2.6
1.5
—
—
—
0
0
20
218
0.91
0.10
1.3
1.2
174.8
116.0
iu/ml
—
6
89
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
45
471
0.95
0.09
8.6
6.1
—
—
—
0
0
6
70
0.86
0.07
1.2
1.2
123.9
17.3
u/l
—
6
62
8
92
0.87
0.07
1.4
1.4
—
—
—
0
0
65
660
0.98
0.02
2.7
2.6
0.5
0.8
ug/l
2.59
45
423
10
102
0.98
0.00
2.6
2.3
31.0
103.3
ug/min
—
5
63
118
1184
1.00
0.00
4.7
3.8
1.4
2.0
ug/l
3.47
103
1053
95
949
1.00
0.00
4.0
3.5
21.5
24.0
%
0.80
44
425
21
205
1.03
0.00
2.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
1.3
—
0
8
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
8
84
0.95
0.00
1.1
1.2
3.8
3.9
mmol/l
—
8
79
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
8
87
0.92
0.00
1.1
1.2
8.0
1468.0
e6/l
—
8
71
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
28.3
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
3.2
—
0
9
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_OESOPHAGUS_EXALLC – Benign neoplasm: Oesophagus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).